Memory Enhancement in Aging With Optimal Dosing
Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age65+
SponsorBoston University Charles River Campus
About this trial
This project optimizes high-resolution tACS to improve memory in healthy older adults, advancing drug-free approaches for ADRD. We test stimulation schedules and develop an adaptive, brain-guided tACS system to strengthen memory-supporting networks.
Eligibility criteria
Qualifiers
65 years of age or older
normal or corrected-to-normal vision
color vision
Disqualifiers
pregnant
metal implants in head
implanted electronic devices
history of neurological problems or head injury
Trial design
Treatments tested in this trial
- 1-day patterned tACS
- 3-day patterned tACS
- 5-day patterned tACS
- 1-day continuous tACS
- 3-day continuous tACS
- 5-day continuous tACS
Treatment groups
240 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Locations
Sponsors and collaborators
Source ClinicalTrials.gov